Lifeway Foods Applauds Recent Scientific Review Highlighting Kefir as a Potential Protective Dietary Supplementation Against ...
November 18 2020 - 12:49PM
Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”),
the leading U.S. supplier of kefir and fermented probiotic products
to support the microbiome commends the recent review published in
Biomedicine &
Pharmacotherapy where it posits the probiotics in kefir
have immune supporting properties that may be of benefit against
infections, including COVID-19.
With the world awaiting a vaccine to combat the novel
coronavirus, consumer demand for products and methods to boost the
immune system and suppress viral infections is on the rise. The
review discusses the following about kefir, the fermented milk made
from kefir grains:
- Kefir and kefir derivatives can suppress viral activity by
modulating immune-system responses and/or causing disruption of
viral adhesion [26,27].
- The antiviral mechanisms of kefir involve enhancement of
macrophage production and boosting the activity of proinflammatory
cytokines [27].
- Kefir dietaries have anti-inflammatory activity by inhibiting
the activity of proinflammatory cytokines such as IL-1β, TNF-α and
IL-6, meaning the nutrients and various biomolecules produced
[27].
“At Lifeway Foods, we are on a mission to keep our communities
healthy, and a big part of that mission is educating consumers that
good health and immunity starts within the gut,” states Julie
Smolyansky, CEO of Lifeway Foods, Inc. “With viral infections like
COVID-19 at the forefront of our minds, it’s important that studies
like this continue to educate and demonstrate to people everywhere
how probiotic products such as kefir may help mitigate the viral
risks we all face. This review builds upon the foundation of Nobel
Prize winner Élie Metchnikoff’s research on immunology. Metchnikoff
is revered for first discovering the connection between immunity
and probiotic fermented milk products, such as kefir, over 100
years ago. Today, we honor his legacy by celebrating the ongoing
research and spreading the word about the benefits of probiotics
and kefir.”
As the leading U.S. supplier of kefir, Lifeway Kefir is made
with 12 active cultures and packed with protein, calcium and
vitamin D. Each product is loaded with probiotics, which research
suggests may help to support the microbiome and protect against
infections. Additionally, probiotic products such as Lifeway Kefir
may help support the body’s response to decrease inflammation.
To learn more about Lifeway and its products, visit
lifewayfoods.com. To view the full review published in Biomedicine
& Pharmacotherapy Volume 133, visit Sciencedirect.com.
About Lifeway Foods
Lifeway Foods, Inc., which has been recognized as one of Forbes’
Best Small Companies, is America’s leading supplier of the
probiotic, fermented beverage known as kefir. In addition to its
line of drinkable kefir, the company also produces cupped kefir and
cheese, frozen kefir, specialty cheeses, probiotic supplements and
a ProBugs line for kids. Lifeway’s tart and tangy fermented dairy
and non-dairy products are now sold across the United States,
Mexico, Ireland and the United Kingdom. Learn how Lifeway is good
for more than just you at www.lifewaykefir.com
Forward-Looking Statements
All statements in this release (and oral statements made
regarding the subjects of this release) contains “forward-looking
statements” as defined in the Private Securities Litigation Reform
Act of 1995 regarding, among other things, future operating and
financial performance, product development, market position,
business strategy and objectives. These statements use words, and
variations of words, such as “expect,” “vision,” “will,” “predict,”
“grow,” and “trend.” Other examples of forward looking statements
may include, but are not limited to, (i) statements of Company
plans and objectives, including the introduction of new products,
or estimates or predictions of actions by customers or suppliers,
(ii) statements of future economic performance, and (III)
statements of assumptions underlying other statements and
statements about Lifeway or its business. You are cautioned not to
rely on these forward-looking statements. These statements are
based on current expectations of future events and thus are
inherently subject to uncertainty. If underlying assumptions prove
inaccurate or known or unknown risks or uncertainties materialize,
actual results could vary materially from Lifeway’s expectations
and projections. These risks, uncertainties, and other factors
include: price competition; the decisions of customers or
consumers; the actions of competitors; changes in the pricing of
commodities; the effects of government regulation; possible delays
in the introduction of new products; and customer acceptance of
products and services. A further list and description of these
risks, uncertainties, and other factors can be found in Lifeway’s
Annual Report on Form 10-K for the fiscal year ended December 31,
2019, and the Company’s subsequent filings with the SEC. Copies of
these filings are available online at https://www.sec.gov,
http://lifewaykefir.com/investor-relations/, or on request from
Lifeway. Information in this release is as of the dates and time
periods indicated herein, and Lifeway does not undertake to update
any of the information contained in these materials, except as
required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY
OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY
ARCHIVED PRESS RELEASE.
References:
[26] G. Vinderola, G. Perdigon, J. Duarte, D. Thangavel,
E. Farnworth, C. Matar, Effects of kefir fractions on innate
immunity, Immunobiology. 211 (3) (2006) 149–156.
[27] H.-L. Chen, K.-F. Hung, C.-C. Yen, C.-H. Laio, J.-L.
Wang, Y.-W. Lan, et al., Kefir peptides alleviate particulate
matter< 4 μm (PM 4.0)-induced pulmonary inflammation by
inhibiting the NF-κB pathway using luciferase transgenic mice, Sci.
Rep. 9 (1) (2019) 1–13.
Media ContactCercone Brown
Company+1 (908)-907-6862lifeway@cerconebrown.com
Lifeway Foods (NASDAQ:LWAY)
Historical Stock Chart
From May 2024 to Jun 2024
Lifeway Foods (NASDAQ:LWAY)
Historical Stock Chart
From Jun 2023 to Jun 2024